Personalized Medicine, Pharmacogenomics, and the Practice of Psychiatry: On the Threshold of Predictive Therapeutics in Psychopharmacology?
- 1 February 2008
- journal article
- trends in-psychopharmacology
- Published by Cambridge University Press (CUP) in CNS Spectrums
- Vol. 13 (2), 115-118
- https://doi.org/10.1017/s1092852900016254
Abstract
Personalizing medicine by understanding the unique properties of each patient's genome has the potential of predicting what drug to prescribe for that individual. This approach has already proven useful for several drugs in medicine and promises to become a strategy for selection of therapeutics in psychiatry soon. Understanding some of the key concepts, strategies, and advances in the field of pharmacogenomics can set the stage for adapting emerging findings to the practice of psychopharmacology.Keywords
This publication has 6 references indexed in Scilit:
- Routine pharmacogenetic testing in clinical practice: dream or reality?Pharmacogenomics, 2007
- Association Between a Functional Serotonin Transporter Promoter Polymorphism and Citalopram Treatment in Adult Outpatients With Major DepressionArchives of General Psychiatry, 2007
- Insights into the role of heritable genetic variation in the pharmacokinetics and pharmacodynamics of anticancer drugsExpert Opinion on Pharmacotherapy, 2007
- Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of researchMolecular Psychiatry, 2007
- Integrating Genomics and Neuromarkers for the Era of Brain-Related Personalized MedicinePersonalized Medicine, 2007
- Pharmacogenetics of Psychotropic Drug ResponseAmerican Journal of Psychiatry, 2004